Olfr584 Inhibitors
Olfr584, a member of the olfactory receptor family, holds a crucial role in the intricate process of olfactory signal transduction. Positioned within the olfactory epithelium, Olfr584 functions as a molecular sensor responsible for detecting specific odorants present in the environment. Upon interaction with odorant molecules, Olfr584 initiates a series of intracellular events that ultimately lead to the generation and transmission of olfactory signals. This process is essential for our ability to perceive and distinguish various smells, contributing significantly to the complex and nuanced human sense of smell. The general mechanisms of inhibiting Olfr584 delve into targeting specific signaling pathways associated with its function. Chemical inhibitors identified in the table exert their effects by modulating key intracellular pathways. For instance, inhibitors such as Fenvalerate and Yohimbine impact calcium and cAMP signaling pathways, respectively, influencing downstream processes crucial for olfactory signal transduction. These indirect inhibitors disrupt secondary messenger systems essential for Olfr584 function, impairing its ability to effectively transduce olfactory signals in response to odorant stimuli.
Furthermore, inhibitors like A769662, SB203580, LY294002, Wortmannin, Sorafenib, U0126, PD98059, SP600125, A443654, and GDC-0879 target MAPK, PI3K, and JNK pathways. Their actions on these pathways interfere with cellular processes vital for olfactory signal transduction, collectively contributing to the inhibition of Olfr584. By understanding and manipulating these intracellular pathways, researchers gain insights into the fundamental mechanisms governing olfactory receptor function. This knowledge not only advances our understanding of olfaction at the molecular level but also provides a foundation for potential applications in research settings where precise modulation of olfactory receptors is desired.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenvalerate | 51630-58-1 | sc-24014 sc-24014A | 25 mg 100 mg | $80.00 $231.00 | 2 | |
Pyrethroid insecticide that modulates the calcium signaling pathway. Its interaction with intracellular calcium levels indirectly inhibits Olfr584 by influencing downstream signaling cascades, disrupting olfactory signal transduction. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Alpha-2 adrenergic receptor antagonist impacting the cAMP signaling pathway. By blocking this pathway, Yohimbine indirectly inhibits Olfr584 expression and function, disrupting the secondary messenger system crucial for olfactory signal transduction. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
AMP-activated protein kinase (AMPK) activator affecting energy homeostasis. Indirectly inhibits Olfr584 by modulating AMPK-mediated pathways, altering cellular metabolic processes that influence olfactory signal transduction. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 mitogen-activated protein kinase (MAPK) inhibitor disrupting inflammatory signaling pathways. Its impact on MAPK cascades indirectly inhibits Olfr584, as the receptor is sensitive to alterations in inflammatory signals in the olfactory system. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Phosphoinositide 3-kinase (PI3K) inhibitor affecting the PI3K/AKT signaling pathway. Indirectly inhibits Olfr584 by disrupting downstream signaling, modulating intracellular processes crucial for olfactory signal transduction. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Phosphatidylinositol 3-kinase (PI3K) inhibitor influencing intracellular signaling cascades. Its impact on PI3K pathways indirectly inhibits Olfr584 by disrupting downstream processes essential for olfactory signal transduction. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Multi-kinase inhibitor affecting RAF/MEK/ERK signaling pathways. Indirectly inhibits Olfr584 by disrupting the MAPK pathway, altering cellular processes involved in olfactory signal transduction. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK1/2 inhibitor targeting the MAPK pathway. Its impact on this pathway indirectly inhibits Olfr584, disrupting downstream signaling cascades essential for olfactory signal transduction. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Selective MEK inhibitor impacting the MAPK pathway. Indirectly inhibits Olfr584 by disrupting the MAPK cascade, altering cellular processes critical for olfactory signal transduction. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
c-Jun N-terminal kinase (JNK) inhibitor influencing stress-related signaling. Its impact on JNK pathways indirectly inhibits Olfr584, disrupting cellular responses associated with stress signaling in the olfactory system. | ||||||